Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -5 of 5
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
1/13/2009
 
First Published:
6/23/2003
1.
Phase III Randomized Study of Interstitial Brachytherapy With or Without External Beam Radiotherapy in Patients With Intermediate-Risk Prostate Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
18 and over
NCI
RTOG-0232
CTSU, NCT00063882
2.
Low Dose Supplemental External Radiation With pd-103 vs pd-103 Alone for Prostate Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
40 to 80
Other
04-8-10
NCT00241384
3.
Pd-103 Dose De-Escalation for Early Stage Prostate Cancer: A Prospective Randomized Trial
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
No age specified
Other
05-8-3
NCT00247312
4.
I-125 Versus Pd-103 for Medium Risk Prostate Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
40 to 90
Other
02-4407-V04
NCT00486499
Last Modified:
1/8/2009
 
First Published:
3/16/2007
5.
Phase II Study of Transperineal Ultrasound-Guided Iodine I 125 or Palladium Pd 103 Brachytherapy in Patients With Locally Recurrent Adenocarcinoma of the Prostate Previously Treated With External-Beam Radiotherapy
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
18 and over
NCI
RTOG-0526
NCT00450411
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute